11 September 2015
: Case report
Neuroendocrine Carcinoma of the Kidney and Bladder with Loss of Heterozygosity and Changes in Chromosome 3 Copy Number
Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Atsushi OkadaABEF, Keitaro IidaB, Takashi HamakawaC, Yukihiro UmemotoD, Takahiro YasuiE, Noriyasu KawaiA, Keiichi TozawaE, Shoichi SasakiF, Yutaro HayashiD, Kenjiro KohriAEDOI: 10.12659/AJCR.894274
Am J Case Rep 2015; 16:611-616
Abstract
BACKGROUND: Neuroendocrine carcinomas (NECs) of the urological organs are observed occasionally, although simultaneous development in the kidney and blabber has not been reported.
CASE REPORT: We report a case of a metastatic NEC of the kidney and bladder in a 77-year-old woman who underwent renal biopsy and transurethral resection of the bladder tumor. Pathological examination revealed NEC in the kidney and the bladder samples. Immunohistochemical examination revealed strongly positive staining for synaptophysin, chromogranin A, and CD56, and focally positive staining for cytokeratin AE 1/3 and Cam 5.2. Fluorescence in situ hybridization confirmed the increased chromosome 3 copy number, and loss of hybridization in 3q21, 5q22-23, 10q26, and 13q14 was detected when the tumor samples were compared with normal samples.
CONCLUSIONS: This is a rare case of NEC-specific genetic abnormalities in a kidney-derived tumor, and is the first report to identify kidney-derived NEC that metastasized to the bladder via the urinary tract.
Keywords: Chromosomes, Human, Pair 3 - genetics, Carcinoma, Neuroendocrine - secondary, Kidney Neoplasms - pathology, Loss of Heterozygosity - genetics, Urinary Bladder Neoplasms - secondary
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946669
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946800
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947628
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947148
Most Viewed Current Articles
21 Jun 2024 : Case report
97,828
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,727
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
32,839
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,613
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030